One Israeli telehealth frontrunner, G Medical Technologies, heading to China International Import Expo (CIIE) this November is looking to market products and build strong partnerships with China.
"Think about Beijing. Think about Guangzhou or Shenzhen or any one of those cities... If you wanna go to the hospital, you will spend two hours (in) each direction. And you will spend seven hours sitting or queuing to see a doctor for one and a half minute," said Yaakov Geva, President and CEO of G Medical Technologies.
Telehealth is one of the top ten medical innovations of 2018, which focuses on diagnosing and treating patients remotely using smartphones and Apps. Geva aims to infiltrate the Chinese market with technology that will eventually render doctor's office visits obsolete.
By using a few simple products attaching to a cell phone, the diagnostic process for the consumer and the physician is simplified and realizes remote control.
For instance, heart patients who apply this chest patch are monitored by an attending physician via a cellphone. Other devices analyze and transmit urine and blood tests to medical personnel on demand.
Medical sector innovation is a pillar of Israel's tech surge. And the country's AI-related startups, including med-tech, raised nearly two billion US dollars in 2017, while 600 million of that came from China.
"Almost every company you talk with, they're talking about China. And China is becoming a player here," said Ilan Maor, Vice President of Israel-China Chamber of Commerce.
"China for us is no question," Geva said, stressing that China offers Israel sizeable market opportunities and substantial growth potential.